Clinical
RSSArticles
-
Clinical Briefs
In this section: A new Parkinson's treatment, type 2 diabetes treatment, and morphine for dyspneic acute heart failure patients.
-
Zoster Vaccine Recombinant Adjuvanted (Shingrix)
Shingrix is indicated for the prevention of herpes zoster in adults ≥ 50 years of age.
-
Fecal Microbiota Testing
Researchers have determined that persons with diabetes or inflammatory bowel disease — or people who have received recent antibacterial therapy — may exhibit very different microbiota profiles. Unfortunately, no one really knows what these differences mean in terms of your overall health.
-
Is a Dabigatran Reversal Agent Effective?
A pragmatic clinical study of idarucizumab for counteracting the effects of the oral anticoagulant dabigatran showed rapid and complete reversal of its effects in patients with major bleeding or urgent surgery, without any adverse safety concerns.
-
Can Medical Therapy Improve Functional Mitral Regurgitation?
Among patients who presented with heart failure with reduced ejection fraction and severe functional mitral regurgitation, mitral regurgitation improved in 38% of patients with medical management. Improvement in mitral regurgitation was associated with increased survival.
-
New Rules Undermine Federal Contraceptive Coverage Guarantee
The regulations leave the coverage guarantee in place, but greatly extend exemptions.
-
Griffithsin Considered as Potential Multipurpose Prevention Technology Option
Researchers now are focusing on an investigational multipurpose prevention technology comprised of griffithsin in a carrageenan gel. While research is in the early stages, the combination approach may lead to a new option to prevent HIV and STIs in an on-demand or sustained use format.
-
Counsel Women About Contraception Guidelines After Bariatric Surgery
Just-published research indicates that while women should avoid conception for the first 18 months following bariatric surgery, 42% of women participating in the 10-site study reported having unprotected intercourse during the 18-month at-risk, post-surgical timeframe.
-
Research Update: Human Papillomavirus Vaccine Safe for Adult Women
In a study of more than 3 million adult women in Denmark and Sweden, results indicate that human papillomavirus (HPV) vaccination was not connected with 44 serious chronic diseases.
-
Intrauterine Device Use Linked With Decrease in Cervical Cancer Incidence
Results of a just-published systematic review indicate that in women who used an intrauterine device, the incidence of cervical cancer was one-third lower.